Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
Felipe Melo-González, Jorge A. Soto, Liliana A González, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1865-1865
Open Access | Times Cited: 16
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Hongyu Liang, Yuyan Wu, Vicky Yau, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1538-1538
Open Access | Times Cited: 15
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
Gaspar A. Pacheco, Catalina A. Andrade, Nicolás M. S. Gálvez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine
Chalerm Liwsrisakun, Supansa Pata, Witida Laopajon, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review
Kenta Fujio, Jaemyoung Sung, Satoru Nakatani, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4500-4500
Open Access | Times Cited: 12
Bioinformatic and Experimental Analysis of T Cell Immune Reactivity to SARS-CoV-2 and its Variants
Alison Tarke, Alba Grifoni, Alessandro Sette
Frontiers in Bioinformatics (2022) Vol. 2
Open Access | Times Cited: 12
Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study
Hao Wang, Mengze Gan, Bihao Wu, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 11
One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test
Yeşim Tok, Rabia Can Sarınoğlu, Seyhan Ördekçi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 6
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Nicolás M. S. Gálvez, Gaspar A. Pacheco, Bárbara M. Schultz, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 10
Gauging the Impact of Artificial Intelligence and Mathematical Modeling in Response to the COVID-19 Pandemic: A Systematic Review
Afshan Hassan, Devendra Prasad, Shalli Rani, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-28
Open Access | Times Cited: 9
LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections
Linmar Rodríguez-Guilarte, Mario A. Ramírez, Catalina A. Andrade, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 147-147
Open Access | Times Cited: 5
COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments
Ahmed Abdeen Hamed, Tamer E. Fandy, Karolina L. Tkaczuk, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 567-567
Open Access | Times Cited: 8
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
Ziyan Meng, Danjing Ma, Suqin Duan, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 929-929
Open Access | Times Cited: 7
Vaccine‐induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review
Zhenkai Zhao, Xiaoning Zhang, Rui Wang, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 7
Contribution of Two-Dose Vaccination Toward the Reduction of COVID-19 Cases, ICU Hospitalizations and Deaths in Chile Assessed Through Explanatory Generalized Additive Models for Location, Scale, and Shape
Humberto Reyes, Benjamín Diethelm‐Varela, Constanza Méndez, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7
A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes
Zaid Alhinai, Sangshin Park, Young June Choe, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 206-211
Open Access | Times Cited: 7
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
Natalie Heinen, Corinna Marheinecke, Clara Bessen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
Alison Tarke, Yun Zhang, Nils Methot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Considerations of COVID-19 in Ophthalmology
Maria Letizia Salvetat, Mutali Musa, Francesco Pellegrini, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2220-2220
Open Access | Times Cited: 4
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type
Арег А. Тотолян, В. С. Смирнов, Alexei A. Krasnov, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2181-2181
Open Access | Times Cited: 4
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Comparison of immune responses induced by two or three doses of an alum‐adjuvanted inactivated SARS‐CoV‐2 vaccine in mice
Ning Luan, Yunfei Wang, Han Cao, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2250-2258
Open Access | Times Cited: 6

Scroll to top